Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.
about
Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza VaccinesInfluenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza VaccinesDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadH7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccineSeasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils.Inactivated influenza virus vaccines: the future of TIV and QIV.Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge ModelPerspectives from the society for pediatric research (SPR): Decreased effectiveness of the live attenuated influenza vaccine (LAIV).Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues.Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial.Immune responses after live attenuated influenza vaccination.Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.Clinical Expectations for Better Influenza Virus Vaccines-Perspectives from the Young Investigators' Point of View
P2860
Q26744622-2B643758-67E2-49A3-B7DB-00FA5376712CQ26783844-E6ED7A3E-8413-4141-9074-B1E8E78C3670Q26783897-BF3D61E2-20D9-47F6-ADFA-AF08519DECA7Q30196901-BBDB9AB9-BFEC-49C1-A315-06CC5E25C139Q30381864-DB33A11C-E844-41F8-B757-413F7D646DDAQ33770702-E5FA296D-9845-4DC0-BABB-C090CAAC48B8Q34520430-30BBC12D-55AA-4716-9088-971A8A268EFBQ35886894-765DEA16-C9C1-455B-B5C0-1FD7918A3121Q36518793-BB0FFD7D-2765-4C80-AA44-057281E4A49DQ37161924-D5B4E7AC-5D9E-457B-B7E0-C9A70273A453Q38683726-DC1BF671-456D-4824-82A9-2450C0DA5F3AQ38998931-6DC4A129-CC7D-4B18-BF0E-DC070792F15FQ41676246-CA2C5D36-8506-4F68-B945-54D8F7C30204Q41930762-39BD0168-6887-4193-905C-CBADA8A20AADQ42872289-EF351254-452F-457F-8D64-4A4C2AE7E491Q47547355-167C09D3-070F-4FAA-AEBD-736ECCEB741BQ47937377-CA7EEEC6-D155-4176-B87F-599B70A4F82DQ54247364-919C5A9C-5A9D-4E59-8557-FA975BC998B8Q56536297-23FE01BE-3763-486E-81EA-8681BCE6FC67
P2860
Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Longevity of B-cell and T-cell ...... uenza vaccination in children.
@ast
Longevity of B-cell and T-cell ...... uenza vaccination in children.
@en
type
label
Longevity of B-cell and T-cell ...... uenza vaccination in children.
@ast
Longevity of B-cell and T-cell ...... uenza vaccination in children.
@en
prefLabel
Longevity of B-cell and T-cell ...... uenza vaccination in children.
@ast
Longevity of B-cell and T-cell ...... uenza vaccination in children.
@en
P2093
P2860
P356
P1476
Longevity of B-cell and T-cell ...... luenza vaccination in children
@en
P2093
Camilla Tøndel
Geir Bredholt
Hans J Aarstad
Kristin G-I Mohn
Rishi D Pathirana
P2860
P304
P356
10.1093/INFDIS/JIU654
P407
P577
2014-11-25T00:00:00Z